PEAK6 Investments LLC - AXSOME THERAPEUTICS INC ownership

AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 201 filers reported holding AXSOME THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.6%.

Quarter-by-quarter ownership
PEAK6 Investments LLC ownership history of AXSOME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,118,240
-61.1%
16,000
-60.0%
0.01%
-61.5%
Q2 2023$2,874,400
+208.6%
40,000
+164.9%
0.01%
+225.0%
Q1 2023$931,368
+141.5%
15,100
+202.0%
0.00%
+100.0%
Q4 2022$385,650
-86.6%
5,000
-87.5%
0.00%
-60.0%
Q2 2022$2,874,40040,0000.01%
Other shareholders
AXSOME THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 1,123,929$42,462,00036.04%
MORGAN JESS S & CO INC 114,525$4,327,0002.66%
Fairmount Funds Management LLC 187,598$7,087,0002.34%
WMS Partners, LLC 242,500$9,162,0001.95%
IRIDIAN ASSET MANAGEMENT LLC/CT 610,064$23,048,0001.41%
MANGROVE PARTNERS IM, LLC 400,000$15,112,0000.90%
RTW INVESTMENTS, LP 1,618,819$61,159,0000.89%
MPM BioImpact LLC 103,405$3,907,0000.71%
Avidity Partners Management LP 775,000$29,280,0000.62%
FIRST MIDWEST BANK TRUST DIVISION 115,028$4,346,0000.56%
View complete list of AXSOME THERAPEUTICS INC shareholders